ABBOTT LABORATORIES Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Abbott Laboratories quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Abbott Laboratories Operating Income (Loss) for the quarter ending September 30, 2024 was $1.86B, a 12.9% increase year-over-year.
  • Abbott Laboratories Operating Income (Loss) for the twelve months ending September 30, 2024 was $6.69B, a 11.5% increase year-over-year.
  • Abbott Laboratories annual Operating Income (Loss) for 2023 was $6.48B, a 22.5% decline from 2022.
  • Abbott Laboratories annual Operating Income (Loss) for 2022 was $8.36B, a 0.75% decline from 2021.
  • Abbott Laboratories annual Operating Income (Loss) for 2021 was $8.43B, a 57.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.69B $1.86B +$212M +12.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $6.48B $1.67B +$127M +8.24% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $6.36B $1.39B -$123M -8.15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $6.48B $1.78B +$476M +36.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $6B $1.65B -$123M -6.95% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $6.13B $1.54B -$834M -35.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $6.96B $1.51B -$1.4B -48.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $8.36B $1.3B -$1.07B -45.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $9.44B $1.77B -$776M -30.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $10.2B $2.38B +$984M +70.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $9.23B $2.91B +$803M +38.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $8.43B $2.38B -$54M -2.22% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $8.48B $2.55B +$1.05B +70.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $7.43B $1.39B +$720M +107% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $6.71B $2.11B +$1.35B +178% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $5.36B $2.43B +$1.04B +75.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $4.31B $1.5B +$297M +24.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $4.02B $672M -$534M -44.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $4.55B $758M +$19M +2.57% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $4.53B $1.39B +$224M +19.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $4.31B $1.2B +$203M +20.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $4.11B $1.21B +$324M +36.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $3.78B $739M +$131M +21.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $3.65B $1.17B +$514M +79% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $3.14B $995M +$226M +29.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $2.91B $882M +$496M +128% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $2.41B $608M +$850M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $1.56B $651M -$138M -17.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $1.7B $769M -$128M -14.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $1.83B $386M -$430M -52.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $2.26B -$242M -$766M -146% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $3.03B $789M -$26M -3.19% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $3.05B $897M +$184M +25.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $2.87B $816M +$87M +11.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $2.78B $524M -$86M -14.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $2.87B $815M -$14M -1.69% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $2.88B $713M -$15M -2.06% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $2.9B $729M +$52M +7.68% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $2.84B $610M +$245M +67.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $2.6B $829M +$411M +98.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $2.19B $728M +$255M +53.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $1.93B $677M +$50M +7.97% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $1.88B $365M -$250M -40.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $2.13B $418M +$441M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $1.69B $473M +$163M +52.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $1.53B $627M +$62.8M +11.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $1.47B $615M +$106M +20.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $1.36B -$23.4M +$2.02B +98.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 -$657M $310M -$285M -47.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$372M $564M -$1.21B -68.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $837M $509M -$792M -60.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $1.63B -$2.04B -$3.87B -212% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-21
Q3 2011 $5.5B $595M -$586M -49.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $6.09B $1.77B +$167M +10.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $5.92B $1.3B -$169M -11.5% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $6.09B $1.83B Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 $1.18B Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $1.61B Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $1.47B Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.